Response to: S. Sega-Jazbec et al.: 'Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis' Multiple Sclerosis and Related Disorders 2017
| Autor: | Katja Thomas, Tjalf Ziemssen |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
medicine.medical_specialty Multiple Sclerosis MEDLINE Antibodies Monoclonal Humanized 03 medical and health sciences 0302 clinical medicine Text mining Multiple Sclerosis Relapsing-Remitting Internal medicine medicine Humans In patient 030212 general & internal medicine Alemtuzumab business.industry Multiple sclerosis General Medicine medicine.disease Neurology Relapsing remitting Monoclonal Neurology (clinical) business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Multiple sclerosis and related disorders. 17 |
| ISSN: | 2211-0356 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect